Merck anticipates animal health divestments in Schering-Plough deal
Merck has conceded that to gain regulatory approval for its purchase of rival Schering-Plough it may have to divest all or a part of Schering’s animal health business, or its own...To view the full article, register now.
Already a subscriber? Click here to view full article